With a passion for animal healthcare, NexVet’s aims for global leadership in veterinary biologics and the empowerment of veterinarians by bringing a pipeline of tools and biologic therapies into best clinical practice that is safe, easier to administer and more convenient therapies for the patients in need. NexVet is committed to transforming animal medicine by making remarkable biologic therapies available to veterinarians, pets, and their families.
Learn More >
Cthulhu Ventures llc
100 Shoreline Hwy • Suite B280
Mill Valley, CA 94941
Tel: 415-444-9602 • Fax: 415-444-9602
info@cthulhuventures.com
Location: Ireland, The Municipal District of Tullamore, Tullamore
Total raised: $38.2M
Investors 1
| Date | Name | Website |
| - | Cthulhu Ve... | cthulhuven... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 16.04.2014 | Series B | $31.5M | - |
| 28.10.2013 | - | $6.7M | - |
Mentions in press and media 4
| Date | Title | Description | Source |
| 29.06.2016 | The biotech IPO feast flags as investors lose their appeti... | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. B... | endpts.com... |
| 16.04.2014 | Nexvet Biopharma Closes US$31.5M Series B Financing | Nexvet Biopharma, a Melbourne, Australia-based veterinary biologic drug developer, closed a US$31.5m... | finsmes.co... |
| 28.10.2013 | Nexvet Biopharma Raises AUD$7M in Capital | Nexvet Biopharma, a Melbourne, Australia-based veterinary monoclonal antibody drug developer, raised... | finsmes.co... |
| 18.09.2012 | Veterinary start-up Nexvet seals $2.5 million seed round | An Australian veterinary medicine developer will use fresh funds to accelerate the clinical and busi... | smartcompa... |